Preferences of US adults with Ph+ALL for first-line treatment with TKI-chemotherapy combinations: A discrete choice experiment. (October 2020) - Ashaye, A.; Thomas, C.; Dalal, M.; Kota, V.; Krucien, N.; Sae-Hau, M.; Barnhart, M.; Weiss, E.; Campbell, S.; Marsh, K.